Bull case
CTA-PA would need investors to value it at roughly 25x earnings — about 12x more generous than today's 14x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where CTA-PA stock could go
CTA-PA would need investors to value it at roughly 25x earnings — about 12x more generous than today's 14x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 19x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 2x multiple contraction could push CTA-PA down roughly 11% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Corteva Agriscience is a global agricultural science company that develops and sells seeds and crop protection products to farmers worldwide. It generates revenue primarily through its Seed segment (~60% of sales) and Crop Protection segment (~40%), which includes herbicides, insecticides, and fungicides. The company's competitive advantage lies in its extensive germplasm library, proprietary trait technologies, and integrated seed-and-chemistry platform that creates switching costs for farmers.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q2 2025 | $0.95/— | — | $4.4B/— | — |
| Q3 2025 | $1.91/— | — | $6.5B/— | — |
| Q4 2025 | —/— | — | $2.6B/— | — |
| Q2 2026 | $1.07/$0.37 | +187.0% | $4.9B/$8.9B | -44.8% |
CTA-PA beat EPS estimates in 1 of 4 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $5M — implies +10167855.3% from today's price.
| Metric | CTA-PA | S&P 500 | Basic Materials | 5Y Avg CTA-PA |
|---|---|---|---|---|
| Forward PE | 13.6x | 19.2x-29% | 14.5x | — |
| Trailing PE | 33.2x | 24.9x+33% | 22.6x+47% | 47.6x-30% |
| PEG Ratio | 0.24x | 1.66x-86% | 1.16x-80% | — |
| EV/EBITDA | 8.5x | 15.3x-45% | 10.6x-20% | 18.4x-54% |
| Price/FCF | 12.8x | 20.9x-39% | 28.3x-55% | 35.1x-64% |
| Price/Sales | 2.1x | 3.1x-34% | 1.8x+18% | 3.4x-39% |
| Dividend Yield | 100.00% | 1.91% | 1.42% | 0.81% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolCTA-PA generates $2.0B in free cash flow at a 11.4% margin — returns 100.0% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
The projected EPS for the next fiscal year has a low confidence score of 43/100, indicating uncertainty in revenue trajectory and margin path.
The Altman Z-Score of 1.98 and StockBond Score of -3.75 suggest elevated financial distress and credit risk.
8-K filings indicate material risks and financial operations, but reliance on regulatory disclosures may lag real-time developments.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
EIDP's 6% dividend yield and $50B market cap suggest financial stability and attractiveness to income-focused investors.
As an established player in agricultural inputs, EIDP is well-positioned to benefit from increasing global food demand.
Potential success in new bio-based products could drive growth and diversify EIDP's revenue streams.
EIDP's regulatory filings are tracked in the SEC EDGAR system, ensuring transparency and accessibility for investors.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
CTA CTA-PA EIDP, Inc. | $35.9B | 13.6x | +4.1% | 6.5% | — | — |
DD DD DuPont de Nemours, Inc. | $19.0B | 57.8x | -12.0% | -0.3% | Buy | -59.1% |
DOW DOW Dow Inc. | $21.1B | 9.2x | +4.6% | -7.0% | Hold | +34.3% |
LYB LYB LyondellBasell Industries N.V. | $18.0B | 5.9x | +2.9% | -3.4% | Hold | +43.6% |
EMN EMN Eastman Chemical Company | $8.1B | 11.1x | +0.1% | 4.6% | Buy | +13.1% |
CE CE Celanese Corporation | $5.5B | 7.9x | +2.7% | -10.8% | Hold | +34.1% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
CTA-PA returns 100.0% total yield, led by a 100.00% dividend. Buybacks add another 3.0%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $2.63 | — | — | — |
| 2025 | $3.50 | 0.0% | — | — |
| 2024 | $3.50 | 0.0% | 2.1% | 3.1% |
| 2023 | $3.50 | 0.0% | 1.6% | 2.5% |
| 2022 | $3.50 | 0.0% | — | — |
Common questions answered from live analyst data and company financials.
EIDP, Inc. (CTA-PA) has limited published analyst coverage at this time. The model scenario range runs from $47 to $99 around a current price of $53. Use the scenario targets and valuation multiples on this page as a guide.
CTA-PA trades at 13.6x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for CTA-PA in 2026 are: (1) Financial Health Risk — The Altman Z-Score of 1. (2) Low EPS Confidence — The projected EPS for the next fiscal year has a low confidence score of 43/100, indicating uncertainty in revenue trajectory and margin path. (3) Regulatory Transparency — 8-K filings indicate material risks and financial operations, but reliance on regulatory disclosures may lag real-time developments. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates CTA-PA will report consensus revenue of $18.6B (+4.1% year-over-year) and EPS of $2.05 for the upcoming fiscal year. The following year, analysts project $19.9B in revenue.
A confirmed upcoming earnings date for CTA-PA is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
EIDP, Inc. (CTA-PA) generated $2.0B in free cash flow over the trailing twelve months — a free cash flow margin of 11.4%. CTA-PA returns capital to shareholders through dividends (100.0% yield) and share repurchases ($1.1B TTM).